Análises de convites de revistas cientificas

emily.parker@glintopenaccess.com
10:59 PM (25 minutes ago)
to me

“Injectable Therapies and Their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases”.

Dear Dr. Sodré GB Neto,
Good day to you.

We are following up on our earlier request regarding your manuscript for Epidemiology and Public Health: Open Access.

Kindly share your full-length article either by attaching it to this email or via our online submission portal.

If you need more time, do let us know when you expect to submit.

Looking forward to your reply.

Best regards,

Emily Parker

Glint Open Access

Publish posted Article Online First: Bioengineering and Biomedical Science Research

Inbox

Sony Hazi sonyhazi@clinmedpub.org
10:30 AM (12 hours ago)
to me

Dear Dr. Sodré GB Neto,

Good day to you.

Your article entitled “ Injectable Therapies and their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases: Obesity, Cancer, and Type 2 Diabetes Mellitus” deserves the best readers.

We introduce ourselves as Advances in of journal of Advances in Bioengineering and Biomedical Science Research ISSN: 2640-4133 which is providing a great platform to serve the scientific community in the field of Medical, Clinical and Bioengineering.

The journal is a peer-reviewed open-access journal having a 1.7 impact factor and is well known for many quality publications.

kindly submit your work on or before 28th NoV, 2025 to this mail as an attachment or ONLINE SUBMISSION.

We are waiting for your response.

With Regards,

Sony Hazi

 

International Journal of Research and Innovation in Applied Science (IJRIAS)

ISSN: 2454-6194 | DOI: 10.51584/IJRIAS

Committed to Quality Research and Innovation Since 2012

November Issue of 2025 | Deadline:  Tomorrow

Dear Author/Researchers, 

We hope this email finds you well. We are pleased to invite you to submit your original research paper to the International Journal of Research and Innovation in Applied Science (IJRIAS) for publication in the November 2025 Issue.

Important Details

Month/Year/Volume/Issue: November Issue of 2025

Submission Method: – Online Manuscript Submission Form

Research Area:  IJRIAS welcomes contributions from a diverse range of disciplines, including:

✔ Applied Science – Mathematics, Physics, Chemistry, Geology, and more.
✔ Engineering & Technology – Mechanical, Civil, Electrical, Computer Science, and related fields.
✔ Environmental Studies – Climate Change, Sustainability, Food Science, and more

Indexing/Abstracted:Google Scholar, Crossref, REPEC, EconPapers, etc.

Reviewer & Board  Members:  5000+ Reviewers & Editorial Teams from around the world (USA, Asia, Africa, Europe, etc. )

Key Points:

✔ DOI for Every Paper – Each article receives a unique DOI from Crossref for increased visibility and citation.
✔ Established Journal – 13+ years of publication history, with an extensive research archive since 2012.
✔ International Editorial Board – 5,000+ expert reviewers and editorial members worldwide.
✔ Rigorous Peer-Review – A strict review process led by subject matter experts ensures quality and originality.
✔ Fast Publication Process – Our streamlined review system ensures timely publication.
✔ Open Access – Your research will be freely accessible worldwide, increasing its impact.
✔ Affordable Publication Fee – Only USD 30, supporting research accessibility and operational costs.

We look forward to receiving your valuable research and sharing it with the global scientific community. Should you have any questions, please feel free to contact our editorial team.

Best regards,
IJRIAS Editorial Team
International Journal of Research and Innovation in Applied Science (IJRIAS)
ISSN: 2454-6194

 
Applied Science Journal ( Peer-Reviewed) 
E ISSN: 2454-6194 | DOI: 10.51584/IJRIAS

Deadline: Tomorrow | Publication Fee: 1500 INR      
Dear Author/Researchers,

We hope this message finds you well.

We invite you to submit your valuable research paper to the International Journal of Research and Innovation in Applied Science (IJRIAS), a respected peer-reviewed, open-access journal. IJRIAS welcomes high-quality research papers across various fields of applied science, including but not limited to engineering, technology, applied sciences, and environmental studies.
Submit your paper through the link below
(Submission Deadline –  Tomorrow)
Important Details 
Areas covered: Applied Science, Mathematics, Engineering, Physics, Chemistry, Geology, Food Science, Environmental Studies, and more.
Editorial & Reviewer:  5000+ reviewers and editorial teams from around the world.
Indexing/Abstracted: Google Scholar, Crossref, IDEAs, REPEC, etc.
Key Highlights
DOI Registration: IJRIAS is registered with Crossref, ensuring your work receives a unique identifier for enhanced discoverability.
Nominal Publication Fee: A minimal fee of INR 1500 is charged to support our operations and the research community.
Rigorous Peer-Review Process: Our peer-review process, conducted through OJS, ensures the quality and originality of each submission, with evaluations made by experts in the relevant fields.
Wide Range of Topics: Encourage research and collaboration, covering various areas within Applied Science to foster diverse perspectives.
Thanks for choosing our Journal.

Thanks,

Shalom

Editorial Office | IJRIAS Journal Team

 

Medical Health & Psychiatry health@scholar.meteorpub.com
Sat, Nov 8, 6:24 AM (2 days ago)

to me

Dear Dr. Sodré Gonçalves de Brito Neto,

Greetings…!

We read your preprint entitled “Integrated Injectable Therapies in the Modulation of Chronic Inflammation in Obesity, Cancer, and Type 2 Diabetes” which is quite interesting and informative.

So, we are glad to invite you to submit your article in our journal. We will be publishing it by rapid peer review process.

Can you submit a Research/ Review/ Case reports for our upcoming issue?

Can you write a Mini-review or short commentary on the same article with 1000-1500-word count for our journal’s upcoming issue which in turn increases the citation of your original article?

If you are interested, please submit through this mail as an attachment through mail

Hope to have a Positive response.

Thanks & regards,
Editorial team
International Cancer Research Journal

Re: Injectable Therapies and their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases: Obesity, Cancer, and Type 2 Diabetes Mellitus
Wren Research Journals <infectious.diseases@wrenjournals.com> Mon, Nov 3, 2025 at 11:40 AM
To: “clinicaltrialinbrazil@gmail.com” <clinicaltrialinbrazil@gmail.com>
                                                    Journal of Infectious Diseases and Patient Care
Dear Dr. Sodré GB Neto,
Greetings.
We recently reviewed your preprint entitled “Injectable Therapies and their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases: Obesity, Cancer, and Type 2 Diabetes Mellitus,” which perfectly aligns with scope of our journal.
We would be honoured to have your full-length preprint article published in our upcoming issue. We will process and publish your manuscript followed by rapid peer review process.
Kindly submit your manuscript by attaching to this Mail ID or by registering through our online submission portal: https://infectiousdiseases-patientcare.wren-research-journals.com/1/user/register
Awaiting for your response.
Thanks and regards,
Editorial Team

Emma Emily Emma.Emily@researchlakejournals.com
Wed, Nov 5, 7:38 AM (5 days ago)
to me

Dear Dr. Sodre GB Neto,

I hope this message finds you well. We have reviewed your preprint article and are impressed with the quality of your work. It aligns closely with the focus of IJDM | Diabetes and offers valuable insights into advancing diabetes management.

We would like to invite you to consider submitting your article for publication in our upcoming issue. We believe your work would be a great addition to the journal and would be of interest to our readership.

For a smooth submission, please take a moment to review our author guidelines and submission policies. You can submit your manuscript through our online portal or directly via email to Emma.Emily@researchlakejournals.com.

The deadline for submissions is November 17, 2025. However, we are open to extending this deadline if necessary. Additionally, please note that we are offering a 50% waiver on Article Processing Charges (APCs) for submissions to Volume 4, Issue 2.

We would be delighted to have your work considered for publication. Please let us know if you are interested in submitting your manuscript.

Best regards,
Emma Emily
Managing Editor, IJDM
Research Lake International Inc | Canada.

mcnh@alliedresearcher.org
Thu, Nov 6, 1:11 PM (4 days ago)
to me

Dear Dr. Sodré GB Neto,

I hope you’re doing well.

I recently read your article, “Injectable Therapies and their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases: Obesity, Cancer, and Type 2 Diabetes Mellitus“, and found it highly relevant to our journal’s scope.

We would be pleased to consider a manuscript from you for publication in the Journal of Medical and Clinical Nursing & Health. If you’re interested, you may submit your work via email attachment. The preferred deadline is November 20  , 2025, but we’re happy to accommodate an extension if needed.

Please feel free to contact me with any questions.

Best regards,
Amelia
Managing Editor

Sarah Michelle Sarah.Michelle@eresearchpapers.com
Thu, Nov 6, 8:42 AM (4 days ago)
to me

Dear Dr. ProfessorSodréGonçalvesdeBritoNeto,

 

Warm greetings from the Journal of Future Medicine and Healthcare Innovation, (ISSN: 3065-7628, USA).

 

“This is a follow-up email regarding submissions. We have not received your response yet so we take the liberty to remind you again. Please respond to this email and let me know your decision”.

 

I recently came across your article entitled, “Injectable Therapies and their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases: Obesity, Cancer, and Type 2 Diabetes Mellitus”, and was impressed by your valuable contribution to the field.

 

We are pleased to invite you to submit your latest research for publication in Volume 3, Issue 2 of JFMHI. The journal welcomes Original Research Articles, Review Papers, Case Studies, and Short Communications in all areas of medicine, healthcare and innovation.

 

Important Details:

  • Submission Deadline: 18 November 2025
  • Acceptance Notification: Within 10–15 days
  • Publication Mode: Online (Open Access)

 

Keywords / Areas of Interest:

  • Future Medicine
  • Healthcare Systems
  • Clinical Innovations
  • Digital Health
  • Biomedical Engineering
  • Public Health

 

Please submit your manuscript directly to this email address.

 

I look forward to your valuable contribution.

 

Warm Regards,
Sarah Michelle
Managing Editor
Journal of Future Medicine and Healthcare Innovation
USA

 

Cathy walter
Wed, Nov 5, 4:05 AM (5 days ago)
to me

Dear Dr. Sodré Neto,

 

Good day to you.

 

I came across your preprint paper and found it to be highly impressive and relevant.

 

If the manuscript is still unpublished, I would like to invite you to submit your preprint for peer reviewed publication.

 

Your response in this regard will help me arrange reviewers for your paper for swift review process.

 

Greatly appreciated if you could submit your article reply email or submission portal at your earliest convenience.

 

Best Regards,

Cathy

Journal of Cancer Research

ISSN: 2578-3726|DOI: 10.64030/2578-3726

from: Cathy walter Cathy.walter@theresearchunion.info
to: clinicaltrialinbrazil@gmail.com
date: Nov 5, 2025, 4:05 AM
subject: Get Published: “Integrated Therapeutic Approaches for Modulating Inflammation in Cancer, Obesity, and Type 2 Diabetes: Injectable Use of DMSO, Coenzyme Q10, Alpha-Lipoic Acid, Curcumin, and miR-146a-Containing Phytotherapeutics”
signed-by: theresearchunion-info.20230601.gappssmtp.com
security:  Standard encryption (TLS) Learn more
: Important according to Google magic.

 

 

 

 

Announcing Early Career Investigator Awardees

Inbox

Harvard Medicine News HarvardMedicineNews@hms.harvard.edu 

Unsubscribe
1:03 PM (10 hours ago)

to me

November 10, 2025

HMS Announces Blavatnik Institute Early Career Investigator Awards
Cross-section of lung tissue shows 6 structures with bright pink outlines and hollow middles, amid purple, green, yellow, and blue dots like a starfield.
Totaling $5 million, the grants fuel high-potential research from 10 of the most exceptional junior faculty members on campus.

Tackling Substance Use Disorders Among Women
View of the torsos and legs of two women sitting on a couch with hands folded in their laps in a therapy-like setting, while another person, blurred in the foreground, speaks to them.
HMS psychiatry professor Shelly F. Greenfield shares concerns, hopes, and action items with the Harvard Radcliffe Institute.
ON YOUTUBE
A young man (Omar Alali) speaks to the camera with a slight smile
VIDEO: Omar Alali, third-year MD student and U.S. Air Force Academy graduate, on honoring and learning from veterans at HMS. See full post.
Banner reading "Earn a Master's degree from Harvard Medical School. Applications are open for all programs. Apply today."
EXTRAS
Nov. 12: Livestream roundtable on mental health research, treatments
Register by Nov. 17 for Nov. 19 MassCPR annual symposium
60 Minutes episode profiles Harvard scientists
Harvard Medical School Logo
This email was sent by: Harvard Medical School
25 Shattuck Street  Boston, MA, 02115
 
Published by Harvard Medical School, Office of Communications and External Relations
© 2025 The President and Fellows of Harvard College

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *